77 related articles for article (PubMed ID: 21416580)
1. A prognostic evaluation of vascular endothelial growth factor in children and young adults with osteosarcoma.
Ługowska I; Woźniak W; Klepacka T; Michalak E; Szamotulska K
Pediatr Blood Cancer; 2011 Jul; 57(1):63-8. PubMed ID: 21416580
[TBL] [Abstract][Full Text] [Related]
2. Does the degree of intratumoural microvessel density and VEGF expression have prognostic significance in osteosarcoma?
Ek ET; Ojaimi J; Kitagawa Y; Choong PF
Oncol Rep; 2006 Jul; 16(1):17-23. PubMed ID: 16786118
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor expression in osteosarcoma.
Charity RM; Foukas AF; Deshmukh NS; Grimer RJ
Clin Orthop Relat Res; 2006 Jul; 448():193-8. PubMed ID: 16826116
[TBL] [Abstract][Full Text] [Related]
4. Expression of osteopontin and vascular endothelial growth factor in benign and malignant bone tumors.
Sulzbacher I; Birner P; Trieb K; Lang S; Chott A
Virchows Arch; 2002 Oct; 441(4):345-9. PubMed ID: 12404059
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive imaging surrogate of angiogenesis in osteosarcoma.
Bajpai J; Gamanagatti S; Sharma MC; Kumar R; Vishnubhatla S; Khan SA; Rastogi S; Malhotra A; Bakhshi S
Pediatr Blood Cancer; 2010 Apr; 54(4):526-31. PubMed ID: 19890899
[TBL] [Abstract][Full Text] [Related]
6. Expression of vascular endothelial growth factor-C and its receptor in osteosarcomas.
Park HR; Min K; Kim HS; Jung WW; Park YK
Pathol Res Pract; 2008; 204(8):575-82. PubMed ID: 18440723
[TBL] [Abstract][Full Text] [Related]
7. VEGF and EMMPRIN expression correlates with survival of patients with osteosarcoma.
Zhou Q; Zhu Y; Deng Z; Long H; Zhang S; Chen X
Surg Oncol; 2011 Mar; 20(1):13-9. PubMed ID: 19836228
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis.
Kaya M; Wada T; Akatsuka T; Kawaguchi S; Nagoya S; Shindoh M; Higashino F; Mezawa F; Okada F; Ishii S
Clin Cancer Res; 2000 Feb; 6(2):572-7. PubMed ID: 10690541
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of the human epidermal growth factor receptor 2 oncogene is not a common feature in osteosarcoma.
Baumhoer D; Smida J; Specht K; Bink K; Quintanilla-Martinez L; Rosemann M; Siggelkow H; Nathrath WB; Atkinson MJ; Bielack S; Jundt G; Nathrath M
Hum Pathol; 2011 Jun; 42(6):859-66. PubMed ID: 21292304
[TBL] [Abstract][Full Text] [Related]
10. VEGF expression as a prognostic marker in osteosarcoma.
Bajpai J; Sharma M; Sreenivas V; Kumar R; Gamnagatti S; Khan SA; Rastogi S; Malhotra A; Bakhshi S
Pediatr Blood Cancer; 2009 Dec; 53(6):1035-9. PubMed ID: 19621435
[TBL] [Abstract][Full Text] [Related]
11. Expression of platelet-derived growth factor-alpha receptor in human osteosarcoma is not a predictor of outcome.
Sulzbacher I; Birner P; Dominkus M; Pichlhofer B; Mazal PR
Pathology; 2010 Dec; 42(7):664-8. PubMed ID: 21080877
[TBL] [Abstract][Full Text] [Related]
12. [Effect of silencing HIF-1alpha by RNA interference on expression of vascular endothelial growth factor in osteosarcoma cell line SaOS-2 under hypoxia].
Wu Q; Yang SH; Wang RY; Ye SN; Xia T; Ma DZ
Ai Zheng; 2005 May; 24(5):531-5. PubMed ID: 15890092
[TBL] [Abstract][Full Text] [Related]
13. Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.
Caronia D; Patiño-García A; Milne RL; Zalacain-Díez M; Pita G; Alonso MR; Moreno LT; Sierrasesumaga-Ariznabarreta L; Benítez J; González-Neira A
Pharmacogenomics J; 2009 Oct; 9(5):347-53. PubMed ID: 19434073
[TBL] [Abstract][Full Text] [Related]
14. [Relationship between vascular endothelial growth factor expression and angiogenesis in osteosarcoma].
Zhao Y; Qiu GX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Dec; 23(6):619-22. PubMed ID: 12901110
[TBL] [Abstract][Full Text] [Related]
15. Dynamic magnetic resonance imaging of regional contrast access as an additional prognostic factor in pediatric osteosarcoma.
Reddick WE; Wang S; Xiong X; Glass JO; Wu S; Kaste SC; Pratt CB; Meyer WH; Fletcher BD
Cancer; 2001 Jun; 91(12):2230-7. PubMed ID: 11413510
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of immunohistochemical expression of ezrin in non-metastatic high-grade osteosarcoma.
Ferrari S; Zanella L; Alberghini M; Palmerini E; Staals E; Bacchini P
Pediatr Blood Cancer; 2008 Apr; 50(4):752-6. PubMed ID: 17886294
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of vascular endothelial growth factor and cyclooxygenase-2 in patients with rectal cancer treated with preoperative radiotherapy.
Giralt J; Navalpotro B; Hermosilla E; de Torres I; Espin E; Reyes V; Cerezo L; de las Heras M; Ramon y Cajal S; Armengol M; Benavente S
Oncology; 2006; 71(5-6):312-9. PubMed ID: 17687192
[TBL] [Abstract][Full Text] [Related]
18. Lymphangiogenesis and angiogenesis in bladder cancer: prognostic implications and regulation by vascular endothelial growth factors-A, -C, and -D.
Miyata Y; Kanda S; Ohba K; Nomata K; Hayashida Y; Eguchi J; Hayashi T; Kanetake H
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):800-6. PubMed ID: 16467091
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of Vascular Endothelial Growth Factor-A expression in Ewing's sarcoma.
Kreuter M; Paulussen M; Boeckeler J; Gerss J; Buerger H; Liebscher C; Kessler T; Jurgens H; Berdel WE; Mesters RM
Eur J Cancer; 2006 Aug; 42(12):1904-11. PubMed ID: 16824746
[TBL] [Abstract][Full Text] [Related]
20. Transferrin receptor-1 and VEGF are prognostic factors for osteosarcoma.
Wu H; Zhang J; Dai R; Xu J; Feng H
J Orthop Surg Res; 2019 Sep; 14(1):296. PubMed ID: 31484533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]